IPO registrations (S-1, F-1) · Registrants

Adaptive Biotechnologies Corp

SEC CIK
1478320 · filings on EDGAR ↗
Former names
Adaptive TCR Corp (2009–2011)
Registration
Form S-1, first filed 2019-05-30, last 2020-01-22; 2 initial registrations, 4 amendments
Outcome
Final prospectus filed 2019-06-27; declared effective 2019-06-26
Industry (SIC)
Biological Products, (No Diagnostic Substances) 2836
Incorporated in
WA
Business address
1165 EASTLAKE AVE E, Seattle, WA 98109
EIN
27-0907024
Ticker
ADPT (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
Adaptive Biotechnologies Corp on the corporate pages

Offering terms

Proposed price range
$18.00–$19.00 per share (S-1/A filed 2019-06-26)
Final price
$20.00 per share, above the range (424B4 filed 2019-06-27, an initial public offering)
Shares sold
15,000,000
Gross proceeds
$300,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol ADPT
Lead underwriters
Goldman Sachs; J.P. Morgan; BofA Securities
Syndicate
Cowen; Guggenheim Securities; William Blair; BTIG

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 10

FiledFormWhat it isName as filedEDGAR
2019-05-30S-1S-1 (registration)Adaptive Biotechnologies Corp0001193125-19-161447 ↗
2019-06-17S-1/AS-1/A (amendment)Adaptive Biotechnologies Corp0001193125-19-174174 ↗
2019-06-19S-1/AS-1/A (amendment)Adaptive Biotechnologies Corp0001193125-19-176598 ↗
2019-06-26S-1/AS-1/A (amendment)Adaptive Biotechnologies Corp0001193125-19-182012 ↗
2019-06-26EFFECTEFFECT (declared effective)Adaptive Biotechnologies Corp9999999995-19-001450 ↗
2019-06-27424B4424B4 (final prospectus)Adaptive Biotechnologies Corp0001193125-19-184483 ↗
2020-01-21S-1S-1 (registration)Adaptive Biotechnologies Corp0001193125-20-011067 ↗
2020-01-22S-1/AS-1/A (amendment)Adaptive Biotechnologies Corp0001193125-20-012051 ↗
2020-01-23EFFECTEFFECT (declared effective)Adaptive Biotechnologies Corp9999999995-20-000152 ↗
2020-01-24424B4424B4 (final prospectus)Adaptive Biotechnologies Corp0001193125-20-014285 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2019-06-26S-1/Aregistration statement$18.00–$19.0015,000,000-Nasdaq ADPT7primary document; range, shares headline, cover names 7document ↗
2019-06-27424B4final prospectus$20.0015,000,000$300,000,000Nasdaq ADPT7primary document; price sentence, shares headline, proceeds table, cover names 7document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
BALDO LANCEOfficerChief Medical Officer172019–2022
BENZENO SHARONOfficerChief Business Development Off; Chief Commercial Ofc Imm Med; Sr VP, Drug Discovery; SVP, Drug Discovery372019–2026
Cohen Chad MOfficerChief Financial Officer392019–2021
Conroy Kevin TDirector52019–2023
DOBMEIER ERICDirector132019–2021
GOEL DAVID E.Director; DirectorOther; Director,TenPercentOwner; Director,TenPercentOwnerOther72019–2021
GRIFFIN MICHELLE RENEEDirector242019–2026
HALVORSEN OLE ANDREASTenPercentOwner92019–2020person page Fuzzy
HERSHBERG ROBERTDirector242019–2026
HILL NANCY LOUISEOfficerEVP, Operations & Program Mana; Senior VP, Operations; Sr Vice President, Operations; SVP, Operations112019–2021
LO FRANCISOfficerChief People Officer352019–2026
Matrix Capital Management Company, LPDirectorOther; Director,TenPercentOwnerOther52019–2021
NEUPERT PETER MDirector122019–2026person page Fuzzy
NOLAN SEAN PATRICKOfficerChief Technology Officer12019
Ott David C.TenPercentOwner92019–2020
Pellini Michael JDirector112019–2025
PISKEL KYLEOfficerChief Financial Officer; Corporate Controller; Principal Accounting Officer222019–2026
ROBINS CHAD MDirector,OfficerCEO and Chairman442019–2026
ROBINS HARLAN SOfficerChief Scientific Officer512019–2026
RUBINSTEIN JULIEOfficerPresident; President and COO582019–2026
SANG CHARLESOfficerSr VP, Clinical Diagnostics; SVP, Clinical Diagnostics; SVP, External Affairs52019–2020
Shabet Rose SharonTenPercentOwner92019–2020
VGE III Portfolio Ltd.TenPercentOwner12019
Viking Global Equities II LPTenPercentOwner42019–2020
Viking Global Equities LPTenPercentOwner12019
Viking Global Equities Master Ltd.TenPercentOwner52019–2020
VIKING GLOBAL INVESTORS LPTenPercentOwner52019–2020
Viking Global Opportunities GP LLCTenPercentOwner42019–2020
Viking Global Opportunities Illiquid Investments Sub-Master LPTenPercentOwner42019–2020
Viking Global Opportunities Portfolio GP LLCTenPercentOwner42019–2020
VIKING GLOBAL PERFORMANCE LLCTenPercentOwner52019–2020
Viking Long Fund GP LLCTenPercentOwner52019–2020
Viking Long Fund Master Ltd.TenPercentOwner52019–2020
ZOLTNERS ANDRIS ADirector42019–2020
Taylor Stacy LOfficerSVP and General Counsel282020–2024
Palaniappan JyotiOfficerSVP, Diagnostics, immunoSEQ Dx; SVP, Diagnostics, T-Detect82020–2021
ADAMS R MARKOfficerChief Operating Officer; Chief Technical Officer; EVP & Chief Operating Officer162020–2023
BOBULSKY SUSANOfficerChief Commercial Officer, MRD; SVP, Diagnostics, clonoSEQ192020–2026
Trigg LeslieDirector42021–2023
OWEN KATEY EINTERZDirector92021–2026
THORSEN HENNINGOfficerSVP, Commercial Operations22021
SOOD NITINOfficerChief Commercial Officer; Chief Commercial Officer, MRD72021–2023
PETERSON TYCHOOfficerChief Financial Officer72022–2024

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2015-05-11Adaptive Biotechnologies CorpBiotechnology$195,099,954$195,099,954161
2015-01-22Adaptive Biotechnologies CorpBiotechnology$93,750,000$93,750,00041
2015-01-21Adaptive Biotechnologies CorpBiotechnology$95,716,444$95,716,444611
2014-04-15Adaptive Biotechnologies CorpBiotechnology$106,999,480$106,999,48062

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationADAPTIVE BIOTECHNOLOGIES CORPORATIONWAState business registriesEIN (EXACT, as the state registration reports it)
Business registrationADAPTIVE BIOTECHNOLOGIES CORPORATIONWAState business registriesEIN (EXACT, as the state registration reports it)
Plan sponsorADAPTIVE BIOTECHNOLOGIES CORPORATIONWAForm 5500 (employee benefit plans)name and state
Federal award recipientADAPTIVE BIOTECHNOLOGIES CORPORATIONWAFederal spending (USAspending)name and state
Form D issuerAdaptive Biotechnologies CorpWAForm D private offeringsCIK (EXACT)
Lobbying clientADAPTIVE BIOTECHNOLOGIESWAFederal lobbying (LDA)name and state
Lobbying clientADAPTIVE BIOTECHNOLOGIESWAFederal lobbying (LDA)name and state
Lobbying clientADAPTIVE BIOTECHNOLOGIESWAFederal lobbying (LDA)name and state
Lobbying clientADAPTIVE BIOTECHNOLOGIES CORPWAFederal lobbying (LDA)name and state
Lobbying registrantADAPTIVE BIOTECHNOLOGIESWAFederal lobbying (LDA)name and state
Paying companyAdaptive Biotechnologies CorporationWAOpen Payments (drug and device company payments)name and state
Patent assigneeAdaptive Biotechnologies CorporationWAPatents (USPTO)name and state
SEC filerAdaptive Biotechnologies CorpSEC filers (EDGAR)CIK (EXACT)
Trademark ownerAdaptive Biotechnologies CorporationWATrademarks (USPTO)name and state
Business registrationAdaptive Biotechnologies CorporationState business registriesname and state
Business registrationAdaptive Biotechnologies CorporationState business registriesname and state
Business registrationAdaptive Biotechnologies CorporationState business registriesname and state
Business registrationAdaptive Biotechnologies CorporationState business registriesname and state
Business registrationADAPTIVE BIOTECHNOLOGIES CorporationState business registriesname and state
Business registrationADAPTIVE BIOTECHNOLOGIES CORPORATIONState business registriesname and state
Business registrationADAPTIVE BIOTECHNOLOGIES CORPORATIONState business registriesname and state
Business registrationADAPTIVE BIOTECHNOLOGIES CORPORATIONState business registriesname and state
Business registrationADAPTIVE BIOTECHNOLOGIES CORPORATIONState business registriesname and state
Business registrationADAPTIVE BIOTECHNOLOGIES CORPORATIONState business registriesname and state
Form 5500 plan sponsorADAPTIVE BIOTECHNOLOGIES CORPORATIONEIN (EXACT)
Person pageOle Andreas HalvorsenPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner)
Person pagePeter M NeupertPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Biological Products, (No Diagnostic Substances), WA first:

More with this interest.

In other datasets, the same topic (Health) in WA:

Interests: Biological Products, (No Diagnostic Substances) · Health